A serotonin-induced N-glycan switch regulates platelet aggregation

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Mercado, Charles P ^a   Quintero, Maritza V ^c   Li, Yicong ^a   Singh, Preeti ^a   Byrd, Alicia K ^a   Talabnin, Krajang ^b   Ishihara, Mayumi ^b   Azadi, Parastoo ^b   Rusch, Nancy J ^a   Kuberan, Balagurunathan ^c   Maroteaux, Luc ^d   Kilic, Fusun ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d INSTITUT DU FER À MOULIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CMPACETYLNEURAMINATE MONOOXYGENASE; MIXED FUNCTION OXIDASE; N ACETYLNEURAMINIC ACID; POLYSACCHARIDE; SEROTONIN;

ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CELL MEMBRANE; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; FLOW CYTOMETRY; FRACTIONATION; GENETICS; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLISM; MOUSE; THROMBOCYTE; THROMBOCYTE AGGREGATION; DRUG EFFECTS;

ANIMALS; BIOLOGICAL MARKERS; BLOOD PLATELETS; CELL MEMBRANE; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, LIQUID; FLOW CYTOMETRY; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MIXED FUNCTION OXYGENASES; N-ACETYLNEURAMINIC ACID; PLATELET AGGREGATION; POLYSACCHARIDES; SEROTONIN;

EID: 84885110765     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02795     Document Type: Article

References (48)

1. Barter, R. & Pearse, A. G. Mammalian enterochromaffin cells as the source of serotonin (5-hydroxytryptamine). J Pathol Bacteriol. 69, 25-31 (1955).
2. Rudnick, G. & Nelson, P. J. Reconstitution of 5-hydroxytryptamine transport from cholate-disrupted platelet plasma membrane vesicles. Biochemistry. 28, 5300-5303 (1978). (Pubitemid 9063067)
3. Vikenes, K., Farstad, M. &Nordrehaug, J. E. Serotonin is associated with coronary artery disease and cardiac events. Circulation. 100, 483-489 (1999). (Pubitemid 29360156)
4. van den Berg, E. K. et al. Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. Circulation. 79, 116-124 (1989). (Pubitemid 19043682)
5. Ni,W.&Watts, S. W. 5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). Clin Exp Pharmacol Physiol. 33, 575-583 (2006). (Pubitemid 43894017)
6. Ban, Y. et al. Impact of increased plasma serotonin levels and carotid atherosclerosis on vascular dementia. Atherosclerosis. 95, 153-159 (2007). (Pubitemid 47561931)
7. Freyburger, W. A. et al. The pharmacology of 5-hydroxytryptamine (serotonin). J Pharmacol Exp Ther. 105, 80-86 (1952).
8. Vanhoutte, P. M. Platelet-derived serotonin, the endothelium, and cardiovascular disease. J. Cardiovasc. Pharmacol. 17(Suppl. 5), S6-12 (1991).
9. Reed, G. L. Platelet Secretion. Platelets. Michelson, A. D. (ed), 309-319 (Academic Press, 2006).
10. White, J. G. Platelet Structure Platelets Michelson, A. D. (ed), 45-75 (Academic Press 2006).
11. Miller, F., Friedman, R., Tanenbaum, J. & Griffin, A. Disseminated intravescular coagulation and acute myoglobinuric renal failure: A consequence of the serotonergic syndrome. J Clin Psychopharm. 11, 277-279 (1991).
12. Roth, B. L. Drugs and valvular heart disease. NEJM. 356, 6-9 (2007).
13. McNicol, A. & Israel, S. J. Platelets and anti-platelet therapy. J Pharmacol Sci. 93, 381-396 (2003). (Pubitemid 38202124)
14. De Clerck, F. F. & Herman, A. G. 5-Hydroxytryptamine and platelet aggregation. Fed Proc. 42, 228-232 (1983). (Pubitemid 13037700)
15. De Clerck, F. F. & Janssen, P. A. Amplification mechanisms in platelet activation and arterial thrombosis. J Hypertens. 8, S87-93 (1990).
16. Nakamura, K., Kariyazono, H., Masuda, H., Sakata, R. & Yamada, K. Effects of sarpogrelate hydrochloride on platelet aggregation, and its relation to the release of serotonin and P-selectin. Blood Coagul Fibrinolysis. 10, 513-519 (1999). (Pubitemid 30013717)
17. Berry, C. N. et al. Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonist. Thromb Haemost 85, 521-528 (2001). (Pubitemid 32233029)
18. Nishihira, K. et al. Inhibition of 5-hydroxytryptamine receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery. J Thromb Haemost. 4, 247-255 (2006).
19. Przyklenk, K. et al. Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis. J ThrombHaemost. 8, 331-340 (2010).
20. Shirakawa, R. et al. Small GTPase Rab4 regulates Ca21-induced a-granule secretion in platelets. J Biol Chem. 275, 33844-33849 (2000).
21. Walther, D. J. et al. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell. 115, 851-862 (2003). (Pubitemid 38058497)
22. Ziu, E. et al. Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin. JMol Cell Cardiol. 5, 1112-1121 (2012).
23. Dale, G. L. et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature. 4, 175-179 (2002). (Pubitemid 34059519)
24. Dale, G. L. Coated-platelets: an emerging component of the procoagulant response. J Thromb Haemost. 3, 2185-2192 (2005). (Pubitemid 41727196)
25. Ottervanger, J. P., Stricker, B. H., Huls, J. &Weeda, J. N. Bleeding attributed to the intake of paroxetine. Am J Psychiatry. 151, 781-782 (1992).
26. Hoffmeister, K. M. et al. Glycosylation restores survival of chilled blood platelets. Science. 301, 1531-1534 (2003). (Pubitemid 37128544)
27. Wandall, H. H. et al. The origin and function of platelet glycosyltransferases. Blood. 120, 626-635 (2012).
28. Kelm, S. & Schauer, R. Sialic acids in molecular and cellular interactions. Int Rev Cytol. 175, 137-240 (1997). (Pubitemid 27309809)
29. Varki, A. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature. 446, 1023-1029 (2007). (Pubitemid 46676064)
30. Chou, H. H. et al. A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci USA. 95, 11751-11756 (1998).
31. Irie, A., Koyama, S., Kozutsumi, Y., Kawasaki, T. & Suzuki, A. The molecular basis for the absence of N-glycolylneuraminic acid in humans. J Biol Chem. 273, 15866-15871 (1998). (Pubitemid 28298210)
32. Mercado, C. P. et al. Impact of elevated plasma serotonin on global gene expression of murine megakaryocytes. PLoS One. 8, e72580 (2013).
33. Bengel, D. et al. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ('Ecstasy') in serotonin transporter deficient mice. Mol Pharmacol. 53, 649-655 (1998). (Pubitemid 28196486)
34. Daniel, J. L. et al.Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem. 273, 2024-2029 (1998). (Pubitemid 28069248)
35. Iizuka, K., Hamaue, N., Machida, T., Hirafuji, M. & Tsuji, M. Beneficial effects of sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, supplemented with pioglitazone on diabetic model mice. Endocr Res. 34, 18-30 (2009).
36. Bir, S. C. et al. New therapeutic approach for impaired arteriogenesis in diabetic mouse hindlimb ischemia. Circ J. 72, 633-640 (2008). (Pubitemid 351695392)
37. Kilic, F. & Rudnick, G. Oligomerization of the serotonin transporter and its functional consequences. Proc Natl Acad Sci USA. 97, 3106-3111 (2000). (Pubitemid 30183263)
38. Anumula, K. R. & Taylor, P. B. A comprehensive procedure for preparation of partially methylated alditol acetates from glycoprotein carbohydrates. Anal Biochem. 203, 101-108 (1992).
39. Domon, B. & Costello, C. E. Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry. Biochemistry. 5, 1534-1543 (1988). (Pubitemid 18077449)
40. Kozutsumi, Y. et al. Reconstitution of CMP-N-acetylneuraminic acid hydroxylation activity using a mouse liver cytosol fraction and soluble cytochrome b5 purified from horse erythrocytes. J Biochem. 110, 429-435 (1991).
41. Shaw, L. et al. CMP-N-acetylneuraminic acid hydroxylase from mouse liver and pig submandibular glands. Interaction with membrane-bound and soluble cytochrome b5-dependent electron transport chains. Eur J Biochem. 219, 1001-1011 (1994). (Pubitemid 24050971)
42. Chenu, S. et al. Reduction of CMP-N-acetylneuraminic acid hydroxylase activity in engineered Chinese hamster ovary cells using an antisense-RNA strategy. Biochim Biophys Acta. 1622, 133-144 (2003). (Pubitemid 36860025)
43. Budd, T. J. et al. Comparison of the N-glycoloylneuraminic and Nacetylneuraminic acid content of platelets and their precursors using high performance anion exchange chromatography. Glycoconj J. 9, 274-278 (1992).
44. Kuberan, B. et al. Analysis of heparan sulfate oligosaccharides with ion pairreverse phase capillary high performance liquid chromatographymicroelectrospray ionization time-of-flight mass spectrometry. J Am Chem Soc. 124, 8707-8718 (2002). (Pubitemid 34791042)
45. Ahmed, A. et al. Serotonin transamidates Rab4 and facilitates its binding to the C terminus of serotonin transporter. J Biol Chem. 283, 9388-9398 (2008).
46. Kawano, T. et al. Molecular cloning of cytidine monophospho- Nacetylneuraminic acid hydroxylase. J Biol Chem. 270, 16458-16463 (1995).
47. Inoue, S., Sato, C. & Kitajima, K. Extensive enrichment of N-glycolylneuraminic acid in extracellular sialoglycoproteins abundantly synthesized and secreted by human cancer cells. Glycobiology. 20, 752-762 (2010).
48. Pham, T. et al. Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium. Blood. 114, 5225-5235 (2009).